Evidence map›Paper›PMID 37594284›Full record

ArticleMicrobiology spectrum2023

Jiyun Park, Lee-Han Kim, Ju Mi Lee, Sangwon Choi, Young-Jin Son, Hee-Jong Hwang, Sung Jae Shin

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jiyun Park *Department of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 Project for Graduate School of Medical Science, Yonsei University College of Medicine , Seoul, South Korea.ORCID 0000-0002-6502-501X
Lee-Han Kim *Department of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 Project for Graduate School of Medical Science, Yonsei University College of Medicine , Seoul, South Korea.
Ju Mi LeeDepartment of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 Project for Graduate School of Medical Science, Yonsei University College of Medicine , Seoul, South Korea.
Sangwon ChoiDepartment of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 Project for Graduate School of Medical Science, Yonsei University College of Medicine , Seoul, South Korea.
Young-Jin SonA&J Science Co., Ltd , Daegu, South Korea.
Hee-Jong HwangA&J Science Co., Ltd , Daegu, South Korea.
Sung Jae ShinDepartment of Microbiology, Institute for Immunology and Immunological Disease, Brain Korea 21 Project for Graduate School of Medical Science, Yonsei University College of Medicine , Seoul, South Korea.ORCID 0000-0003-0854-4582
Yonsei University · KR

Funding

Korea Health Industry Development Institute (KHIDI) HI22C2047
6 · The paper itself

Abstract

importanceNovel antibiotics for the treatment of MAC infection are urgently needed because the treatment outcomes using the standard regimen for

Indexed as

intracellular activitymacrolide-resistant MACmicrococcin p2minimum inhibitory concentrationMycobacterium avium complexthiopeptide derivatives

Identifiers

PMID37594284
PMCPMC10580953
OpenAlexW4385968786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.